U.S. could authorize Pfizer COVID-19 shot for kids age 5-11 in October -sources
Top U.S. health officials believe that Pfizer Inc's COVID-19 vaccine could be authorized for children aged 5-11 years old by the end of October, two sources familiar with the situation said on Friday.
www.reuters.com
Sept 10 (Reuters) - Top U.S. health officials believe that Pfizer Inc's (PFE.N) COVID-19 vaccine could be authorized for children aged 5-11 years old by the end of October, two sources familiar with the situation said on Friday.
The timeline is based on the expectation that Pfizer, which developed the shot with Germany's BioNTech (22UAy.DE), will have enough data from clinical trials to seek emergency use authorization (EUA) for that age group from the U.S. Food and Drug Administration (FDA) towards the end of this month, the sources said
Good, this can't come soon enough. Kids under 12 are the last group that needs to be protected.